114 related articles for article (PubMed ID: 38706121)
1. Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines.
Schiavoni V; Emanuelli M; Campagna R; Cecati M; Sartini D; Milanese G; Galosi AB; Pozzi V; Salvolini E
J Cell Biochem; 2024 May; ():. PubMed ID: 38706121
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin.
Campagna R; Bacchetti T; Salvolini E; Pozzi V; Molinelli E; Brisigotti V; Sartini D; Campanati A; Ferretti G; Offidani A; Emanuelli M
Antioxidants (Basel); 2020 Dec; 9(12):. PubMed ID: 33297311
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
Xue S; Li QW; Che JP; Guo Y; Yang FQ; Zheng JH
Int J Clin Exp Pathol; 2015; 8(4):3765-74. PubMed ID: 26097558
[TBL] [Abstract][Full Text] [Related]
7. Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines.
Campagna R; Belloni A; Pozzi V; Salvucci A; Notarstefano V; Togni L; Mascitti M; Sartini D; Giorgini E; Salvolini E; Santarelli A; Lo Muzio L; Emanuelli M
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613780
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma.
Xue S; Jiang SQ; Li QW; Wang S; Li J; Yang S; Zhang HM; Xu YF; Wang LS; Zheng JH
BMC Urol; 2018 Sep; 18(1):79. PubMed ID: 30200918
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance.
Campagna R; Pozzi V; Giorgini S; Morichetti D; Goteri G; Sartini D; Serritelli EN; Emanuelli M
Hum Cell; 2023 May; 36(3):1108-1119. PubMed ID: 36897549
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies.
Schiavoni V; Campagna R; Pozzi V; Cecati M; Milanese G; Sartini D; Salvolini E; Galosi AB; Emanuelli M
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370817
[TBL] [Abstract][Full Text] [Related]
11. HIF2α-induced upregulation of RNASET2 promotes triglyceride synthesis and enhances cell migration in clear cell renal cell carcinoma.
Quan Y; Dai J; Zhou S; Zhao L; Jin L; Long Y; Liu S; Hu Y; Liu Y; Zhao J; Ding Z
FEBS Open Bio; 2023 Apr; 13(4):638-654. PubMed ID: 36728187
[TBL] [Abstract][Full Text] [Related]
12. LINC01480 as a Prognostic Biomarker Associated With Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma.
Ma Y; Wu C; Deng S
Anticancer Res; 2023 Jul; 43(7):3037-3046. PubMed ID: 37351956
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of the miR-25-IMPA2 axis promotes metastatic progression in clear cell renal cell carcinoma.
Lin YF; Chou JL; Chang JS; Chiu IJ; Chiu HW; Lin YF
EBioMedicine; 2019 Jul; 45():220-230. PubMed ID: 31202813
[TBL] [Abstract][Full Text] [Related]
14. Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma.
Li C; Guo L; Chen F; Yu W; Rao T; Ruan Y
Oncol Res Treat; 2020; 43(6):264-275. PubMed ID: 32403105
[TBL] [Abstract][Full Text] [Related]
15. Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression.
Fumarola S; Cecati M; Sartini D; Ferretti G; Milanese G; Galosi AB; Pozzi V; Campagna R; Morresi C; Emanuelli M; Bacchetti T
Antioxidants (Basel); 2020 Feb; 9(2):. PubMed ID: 32093309
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
[TBL] [Abstract][Full Text] [Related]
17. The lncRNA SNHG5-mediated miR-205-5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1.
Xiang W; Lv L; Zhou G; Wu W; Yuan J; Zhang C; Jiang G
Cancer Med; 2020 Jun; 9(12):4251-4264. PubMed ID: 32281285
[TBL] [Abstract][Full Text] [Related]
18. MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition.
He A; He S; Huang C; Chen Z; Wu Y; Gong Y; Li X; Zhou L
Aging (Albany NY); 2020 Jan; 12(2):1465-1487. PubMed ID: 31978894
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-424-5p Suppresses Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma and Attenuates Expression of O-GlcNAc-Transferase.
Kalantzakos TJ; Sullivan TB; Gloria T; Canes D; Moinzadeh A; Rieger-Christ KM
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680309
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Transmembrane protein 40 by miR-138-5p Suppresses Cell Proliferation and Mobility in Clear Cell Renal Cell Carcinoma.
Liu D; Zhou G; Shi H; Chen B; Sun X; Zhang X
Iran J Biotechnol; 2020 Jan; 18(1):e2270. PubMed ID: 32884956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
